임상시험

Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma

NCT: NCT07110233 · NOT_YET_RECRUITING

NCT IDNCT07110233

상태NOT_YET_RECRUITING

시작일2026-10-01

완료2029-03-31

SponsorUniversity of California, San Francisco (OTHER)

First posted2025-08-07

Last updated2026-10-06

간략 요약

This is a prospective, single-blinded, single-arm, open-label Phase II trial of trans-arterial radiation segmentectomy using Yttrium-90 glass microspheres (TheraSphere®) for Hepatocellular Carcinoma (HCC) participants with unresectable Barcelona clinic liver cancer (BCLC) stage A disease.

공식 출처

ClinicalTrials.gov에서 보기 →

데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.